Worldwide, research attempts exist to identify the exact role of this receptor in abnormal cell proliferation in pancreatic cancer and periampullary tumors in general for anti-HER2 targeted therapy development. The gene discussed is ERBB2; the disease is familial pancreatic carcinoma.